← Leaderboards
Sharon Pitteri
Stanford University
$2,838,162
Attributed
$6,674,661
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,674,661 · 5
By mechanism
U01$4,912,287 · 2
R25$967,005 · 1
R21$795,369 · 2
Top collaborators
- Carolyn R Bertozzi9 shared
- James D Brooks8 shared
- Utkan Demirci3 shared
Most similar at Stanford University
Same institution · by research overlap
- James D Brooks$12,828,912
- Donna M Peehl$4,923,077
- Calvin J Kuo$48,363,495
- Shan X. Wang$16,205,138
- Irving Lerner Weissman$56,491,773
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsGlycoproteomicsShapesGlycoproteinsBiologicalGlycosylationCancer BiomarkersSamplingPatternInvestigationSiteInterestCollectionClinical TranslationTumorTumor TissueProtein IsoformsBiological MarkersCellsSuccessMeasurementMalignant NeoplasmsSugarValidation
Grant awards (15)
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM$256,009
R25 · FY2025 · CA
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM$292,383
R25 · FY2024 · CA
Identification of serum protein biomarkers by profiling N-glycoproteomes of patient-derived xenografts of neuroendocrine prostate cancer$171,759
R21 · FY2024 · CA
Glycosylation and Immune Evasion in Urologic Tumors$583,786
U01 · FY2023 · CA · contact PI
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM$418,613
R25 · FY2023 · CA
Identification of serum protein biomarkers by profiling N-glycoproteomes of patient-derived xenografts of neuroendocrine prostate cancer$217,991
R21 · FY2023 · CA
Glycosylation and Immune Evasion in Urologic Tumors$588,870
U01 · FY2022 · CA · contact PI
Glycosylation and Immune Evasion in Urologic Tumors$582,341
U01 · FY2021 · CA · contact PI
Identification of serum protein biomarkers by profiling N-glycoproteomes of patient-derived xenografts of clear cell renal cell carcinoma$405,619
R21 · FY2021 · CA
Glycosylation and Immune Evasion in Urologic Tumors$618,139
U01 · FY2020 · CA · contact PI
Glycosylation and Immune Evasion in Urologic Tumors$621,878
U01 · FY2019 · CA · contact PI
Making glycoproteomics via mass spectrometry more accessible to the greater scientific community$125,200
U01 · FY2019 · CA
Making glycoproteomics via mass spectrometry more accessible to the greater scientific community$588,286
U01 · FY2018 · CA
Making glycoproteomics via mass spectrometry more accessible to the greater scientific community$599,528
U01 · FY2017 · CA
Making glycoproteomics via mass spectrometry more accessible to the greater scientific community$604,259
U01 · FY2016 · CA